Clinical Laserthermia Systems has been granted a patent for an apparatus and method for anti-tumour immunologic response through thermotherapy. The device includes a heating probe with an optical fiber and cooling catheter, controlled by a thermal sensor for precise temperature regulation during treatment. GlobalData’s report on Clinical Laserthermia Systems gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Premium Insights Clinical Laserthermia Systems AB - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Clinical Laserthermia Systems, Vaping device aerosol generators was a key innovation area identified from patents. Clinical Laserthermia Systems's grant share as of February 2024 was 70%. Grant share is based on the ratio of number of grants to total number of patents.

Method of controlling tissue heating process for tumour treatment

Source: United States Patent and Trademark Office (USPTO). Credit: Clinical Laserthermia Systems AB

A recently granted patent (Publication Number: US11850442B2) discloses a method for controlling a tissue heating process. The method involves approximating a boundary of a pre-defined treatment lesion, obtaining temperature values from inside or outside the boundary, positioning a heat generator inside the boundary, initiating a warm-up period to reach a target temperature, and maintaining the temperature during the treatment period to obtain a treatment lesion. The method also includes obtaining temperatures at specific distances from the boundary and the heat generator, using thermal sensors, and inactivating the heat generator if the target temperature is reached outside a predefined time range.

Furthermore, the patent includes claims related to controlling the heat generator during the treatment period, obtaining temperatures adjacent to organs at risk, using different types of heat generators (such as light emitting devices), and connecting the heat generator to continuous or pulsed light sources. The patent also covers a system for controlling the tissue heating process, comprising a control unit for approximating the treatment lesion boundary, receiving temperature values, and controlling the heat generator during warm-up and treatment periods. The system is designed to provide warnings and inactivate the heat generator if necessary, ensuring precise control over the tissue heating process. Additionally, the system can be integrated with imaging modalities like MRI and ultrasound for enhanced monitoring and control.

To know more about GlobalData’s detailed insights on Clinical Laserthermia Systems, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.